TrialEsophagus : official journal of the Japan Esophageal Society2021

Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3).

Masanobu Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.